Literature DB >> 54780

Letter: Clonidine withdrawal.

S A Cairns, A J Marshall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54780     DOI: 10.1016/s0140-6736(76)90131-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Rebound phenomenon during gradual withdrawal of clonidine.

Authors:  R Vanholder; J Carpentier; M Schurgers; D L Clement
Journal:  Br Med J       Date:  1977-04-30

Review 3.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

4.  Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.

Authors:  T Rosenthal; B Rabinowitz; H Boichis; E Elazar; A Brauner; H N Neufeld
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Long-term clonidine effects on autonomic function in essential hypertensive man.

Authors:  I M Cohen; D T O'Connor; R A Preston; R A Stone
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

6.  Long-term experience with the combination of clonidine and beta-adrenoceptor blocking agents in hypertension.

Authors:  R Vanholder; N Lameire; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.